Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients

Clinical trial NCT04861337 · COMPLETED

Trial details

NCT number: NCT04861337
Sponsor: Peking University First Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Postoperative Nausea and Vomiting Benzodiazepine High-risk Patients

Start date: 2021-05-19
Primary completion: 2022-12-31
Enrollment: 552

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.